World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
24688
World Ranking
1877
National Ranking
916

Overview

Michael Piatak is affiliated with Leidos in the United States. Their research primarily covers areas within Immunology and Microbiology as well as Medicine. Specific subfields of study include Virology, Immunology, Epidemiology, and Cell Biology.

The scientist's work focuses on several key topics, including:

  • HIV Research and Treatment
  • Virology and Viral Diseases
  • Immune Cell Function and Interaction
  • Interferon and Immune Responses
  • Herpesvirus Infections and Treatments
  • Cellular Transport and Secretion
  • Immune Responses and Vaccinations

Michael Piatak has authored multiple papers, with recent publications spanning from 2020 to 2022. The following are notable examples along with their year of publication and the venues in which they appeared:

  • "IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health," 2022, JCI Insight
  • "A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection," 2022, PLoS Pathogens
  • "A tyrosine-based trafficking signal in the simian immunodeficiency virus envelope cytoplasmic domain is strongly selected for in pathogenic SIV infection," 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • "Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques," 2020, UNC Libraries

The venues in which Michael Piatak has published their research include:

  • JCI Insight
  • PLoS Pathogens
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

The scientist collaborates frequently with several co-authors, which include:

  • Jeffrey D. Lifson
  • Scott P. Lawrence
  • Samra E. Elser
  • Workineh Torben
  • Robert V. Blair

Best Publications

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

    Piatak M;Saag Ms;Yang Lc;Clark Sj

  • Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

    Scott G. Hansen;Julia C. Ford;Matthew S. Lewis;Abigail B. Ventura

  • Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

    Scott G Hansen;Cassandra Vieville;Nathan Whizin;Lia Coyne-Johnson

  • Immune clearance of highly pathogenic SIV infection

    Scott G. Hansen;Michael Piatak;Abigail B. Ventura;Colette M. Hughes

  • Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

    Deborah Persaud;Carrie Ziemniak;Ya Hui Chen

  • Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

    Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet

  • B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.

    Yoshinori Fukazawa;Richard Lum;Afam A Okoye;Haesun Park

  • Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells

    Stuart G. Turville;John J. Santos;Ines Frank;Paul U. Cameron

  • Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species

    M. Piatak;Ka-Cheung Luk;B. Williams;J. D. Lifson

  • Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

    Michael M Lederman;Ronald S Veazey;Robin Ewart Offord;Donald E Mosier

  • Reversion of CTL escape-variant immunodeficiency viruses in vivo.

    Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov

  • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

    V M Hirsch;T R Fuerst;G Sutter;M W Carroll

  • Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

    A. Nichole Cline;Julian W. Bess;Michael Jr Piatak;Jeffrey D. Lifson

  • Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

    Francesco R. Simonetti;Michele D. Sobolewski;Elizabeth Fyne;Wei Shao

  • Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection

    Louis J. Picker;Shoko I. Hagen;Richard Lum;Edward F. Reed-Inderbitzin

  • AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

    Matthew R. Gardner;Lisa M. Kattenhorn;Hema R. Kondur;Markus von Schaewen

  • Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

    Anthony R. Cillo;Michele D. Sobolewski;Ronald J. Bosch;Elizabeth Fyne

  • Protective Efficacy of Adenovirus/Protein Vaccines Against SIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Galit Alter;Thomas Broge;Caitlyn Linde

  • Defining HIV and SIV Reservoirs in Lymphoid Tissues.

    Claire Deleage;Stephen W. Wietgrefe;Gregory Del Prete;David R. Morcock

  • Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection

    Afam A. Okoye;Martin Meier-Schellersheim;Jason M. Brenchley;Shoko I Hagen

  • Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment

    Jeffrey D. Lifson;Jeffrey L. Rossio;Michael Piatak;Thomas Parks

Frequent Co-Authors

Jeffrey D. Lifson
Jeffrey D. Lifson Leidos (United States)
Agegnehu Gettie
Agegnehu Gettie Aaron Diamond AIDS Research Center
Louis J. Picker
Louis J. Picker Oregon Health & Science University
Michael K. Axthelm
Michael K. Axthelm Oregon National Primate Research Center
James Blanchard
James Blanchard Tulane University
R. Paul Johnson
R. Paul Johnson Emory University
Ronald S. Veazey
Ronald S. Veazey Tulane University
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Brandon F. Keele
Brandon F. Keele National Institutes of Health
Jay A. Nelson
Jay A. Nelson Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring health-related online degrees can offer diverse career opportunities. Many students pivot from immunology to nursing fields, where foundational biological knowledge is highly valued. Programs like the best online rn programs for non nurses provide a streamlined path for individuals without a prior nursing background to enter this essential healthcare profession.

Accelerated routes, such as the 12-month accelerated nursing programs, are designed for those eager to quickly transition into clinical roles. These programs demand commitment but significantly shorten the timeline to becoming a Registered Nurse (RN), a role closely linked to immunological patient care and research.

For students seeking more accessible entry points, lpn schools easy to get into offer foundational training in nursing, often requiring less time and allowing for practical experience in healthcare settings that intersect with immunology.

Advancing further, the easiest np program options provide pathways to becoming a Nurse Practitioner, enabling professionals to specialize in areas like immunology for patient diagnosis and treatment. These degree pathways collectively illustrate a flexible and comprehensive approach to careers related to immunology in the USA.

Best Scientists Citing Michael Piatak

Trending Scientists

Recently Published Articles